Dosimetric guidance on using brachytherapy (low-dose-rate or high-dose-rate) to offset a flawed permanent prostate implant

被引:1
作者
Zaider, Marco [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA
关键词
Prostate cancer; Brachytherapy; Permanent implants; High-dose-rate brachytherapy; Salvage brachytherapy; FRACTIONATED RADIOTHERAPY; CANCER; RADIATION; SURVIVAL; IRRADIATION; FORMULATION; MODEL;
D O I
10.1016/j.brachy.2008.10.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE: To provide practical dosimetric advice on mending suboptimal permanent implants using low-dose-rate (LDR) or high-dose-rate (HDR) brachytherapy. The problem is to make the combination of the two radiation treatments (the initial, flawed one and the compensatory boost) clinically isoeffective with the planned dose. METHODS AND MATERIALS: The device of isoeffective dose is the appropriate tool for this purpose as it accounts for the physics (temporal distribution of dose) and biologic (radiosensitivity, repair kinetics, proliferation rate) treatment settings. RESULTS: I give, as a function of separation time from the initial, flawed treatment, and stratified by risk group representative values for the additional dose (low-dose-rate or high-dose-rate) needed to make the combined treatment isoeffective with a prescription of 144 Gy of permanently im-planted planted 1251 seeds. CONCLUSIONS: Although the isoeffective dose concept, within the constraints stated in the text, is rigorously valid, its practical implementation depends importantly on the relevant radiobiologic, parameters, and in this respect the reader is urged to use his own critical judgment. (c) 2009 American Brachytherapy Society. Publish Elsevier Inc. All fights reserved.
引用
收藏
页码:40 / 44
页数:5
相关论文
共 23 条
[1]  
Bice W S Jr, 2000, Tech Urol, V6, P151
[2]   Palladium-103 brachytherapy for prostate carcinoma [J].
Blasko, JC ;
Grimm, PD ;
Sylvester, JE ;
Badiozamani, KR ;
Hoak, D ;
Cavanagh, W .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 46 (04) :839-850
[3]   Modern day-case anaesthesia for children [J].
Brennan, LJ .
BRITISH JOURNAL OF ANAESTHESIA, 1999, 83 (01) :91-103
[4]   FRACTIONATED HIGH DOSE-RATE VERSUS LOW DOSE-RATE REGIMENS FOR INTRACAVITARY BRACHYTHERAPY OF THE CERVIX - EQUIVALENT REGIMENS FOR COMBINED BRACHYTHERAPY AND EXTERNAL IRRADIATION [J].
BRENNER, DJ ;
HUANG, Y ;
HALL, EJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (06) :1415-1423
[6]   THE LINEAR-QUADRATIC FORMULA AND PROGRESS IN FRACTIONATED RADIOTHERAPY [J].
FOWLER, JF .
BRITISH JOURNAL OF RADIOLOGY, 1989, 62 (740) :679-694
[7]   10-year biochemical (prostate-specific antigen) control of prostate cancer with 125I brachytherapy [J].
Grimm, PD ;
Blasko, JC ;
Sylvester, JE ;
Meier, RM ;
Cavanagh, W .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (01) :31-40
[8]   Distribution of the number of clonogens surviving fractionated radiotherapy: a long-standing problem revisited [J].
Hanin, LG ;
Zaider, M ;
Yakovlev, AY .
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2001, 77 (02) :205-213
[9]   Iterated birth and death process as a model of radiation cell survival [J].
Hanin, LG .
MATHEMATICAL BIOSCIENCES, 2001, 169 (01) :89-107
[10]   A comment on proliferation rates in human prostate cancer [J].
Haustermans, K ;
Fowler, JF .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (01) :303-303